BioXcel Therapeutics, Inc.
Ticker: 1720893
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 0.18-14.3% | 0.21+110.0% | 0.10-16.7% | 0.12-29.4% | 0.17-19.0% | 0.21-80.9% | 1.10+89.7% | 0.58 |
| Total Income | 0.18-14.3% | 0.21+110.0% | 0.10-16.7% | 0.12-29.4% | 0.17-19.0% | 0.21-80.9% | 1.10+89.7% | 0.58 |
| EXPENSES | ||||||||
| Expenditure | 10.38-0.5% | 10.43-27.2% | 14.33-10.3% | 15.97+55.5% | 10.27-33.8% | 15.51-15.7% | 18.40-25.7% | 24.75 |
| PROFIT | ||||||||
| Net Profit | -14.71-15.9% | -12.69+58.9% | -30.91-61.1% | -19.19-164.7% | -7.25+46.9% | -13.65-64.5% | -8.30+69.0% | -26.79 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.49+9.3% | -0.54+75.2% | -2.18+11.0% | -2.45-63.3% | -1.50-368.7% | -0.32-52.4% | -0.21+75.9% | -0.87 |
Corporate Events
Board MeetingBTAI
202630Oct
Board Meeting
Termination of Vimal Mehta, Ph.D. (CEO and President) and Ri…
SEC Filing ↗